|
1. |
THE CASE FOR LOCAL IMMUNOSUPPRESSION |
|
Transplantation,
Volume 54,
Issue 1,
1992,
Page 1-11
SCOTT GRUBER,
Preview
|
PDF (1241KB)
|
|
ISSN:0041-1337
出版商:OVID
年代:1992
数据来源: OVID
|
2. |
A CANINE MODEL FOR HEPATIC VENOOCCLUSIVE DISEASE |
|
Transplantation,
Volume 54,
Issue 1,
1992,
Page 12-16
ROBERT EPSTEIN,
KYUNG MIN,
STACY ANDERSON,
LISA SYZEK,
Preview
|
PDF (600KB)
|
|
摘要:
Hepatic venoocclusive disease is a frequent lethal complication of bone marrow transplantation. It has also been associated with hepatic irradiation and administration of chemotherapeutic agents without BMT. The pathogenesis and therapy of VOD are unclear. The present studies were directed at developing a canine model for VOD. Three groups of dogs were studied. Group one consisted of 8 dogs in which monocrotaline (MC) was administered at 125 mg/kg orally on an intermittent schedule. In 7 of the 8 dogs 6 to 9 doses of drug were administered between 42 and 110 days. Group 2 consisted of 6 dogs receiving busulfan 2 mg/kg/day for 17–25 days, when platelet counts decreased to <5×104/mm3or clinical bleeding occurred. Group 3 consisted of 2 dogs receiving 24 Gy and 4 dogs receiving 36 Gy of whole-liver irradiation. Seven of 8 dogs in group 1 developed significant liver function abnormalities and evidence of portal hypertension. Histologic findings of VOD were present at autopsy. Group 2 dogs failed to develop clinical or laboratory liver abnormalities, but 3 of 6 animals had minimal histologic evidence of VOD. Three of 6 dogs in group 3 receiving 36 Gy developed hepatic dysfunction and had findings of fibrosis at autopsy. It was concluded that MC administration produced consistent clinical and histologic features of VOD in dogs. Changes occurring after busulfan or total-liver irradiation administration were less reproducible. Dogs are a suitable large-animal model for studies of VOD.
ISSN:0041-1337
出版商:OVID
年代:1992
数据来源: OVID
|
3. |
DIFFERENTIAL EFFECTS OF PREEXISTING UREMIA AND A SYNCHRONOUS KIDNEY GRAFT ON PANCREAS ALLOGRAFT FUNCTIONAL SURVIVAL IN RATS |
|
Transplantation,
Volume 54,
Issue 1,
1992,
Page 17-25
ICHIRO NAKAI,
DIXON KAUFMAN,
M. FIELD,
PHILIPPE MOREL,
DAVID SUTHERLAND,
Preview
|
PDF (940KB)
|
|
摘要:
Pancreas transplant results have been better in uremic recipients of a simultaneous kidney than in nonuremic recipients of a pancreas alone. We studied the relative effect of uremia versus a double transplant on functional survival by performing bladder-drained pancreas transplants alone (PTA), kidney transplants alone (KTA), and simultaneous pancreas/kidney (SPK) transplants from Buffalo donors to diabetic Lewis rat recipients that were or were not made uremic 2–3 weeks before by 1/5native nephrectomy. Pancreas graft exocrine function was monitored by urinary amylase (UA). In the PTA and SPK recipients made diabetic by streptozotocin, endocrine function was monitored by measuring nonfasting plasma glucose (PG) levels. Kidney graft function was monitored by plasma creatinine (Cr). Rejection of the endocrine pancreas was defined as an increase of PG to >200 mg/dl; of the exocrine pancreas, as a decline in UA to <6000 U/L or to <100 U/24 hr; and of the kidney, as an elevation of Cr to >3 mg/dl. The mean functional survival times (MST) of both the endocrine (12.0±2.1 versus 10.1±1.1 days, P=0.036) and exocrine (8.0±2.1 versus 6.3±1.3 days, P=0.016) components of the pancreas grafts were significantly longer in SPK than in PTA recipients. The MST of kidney allografts, however, was not significantly longer in nonuremic SPK than nonuremic KTA recipients (6.7 ± 1.4 versus 5.7 ± 0.7 days, P=0.13). In parallel experiments in recipients immunosuppressed with cyclosporine, the graft survival times were longer, but the relative differences between the PTA, SPK, and KTA groups persisted. Histologically, lymphocyte infiltration began in the two organs almost simultaneously, but the severity of the rejection was more vigorous in the kidney than in the pancreas in doubly grafted rats, and destruction of pancreas grafts progressed more slowly in SPK than in PTA recipients. Preexisting uremia delayed pancreas rejection in both SPK (exocrine 10.6±2.3, P=0.032, and endocrine 14.8±3.4 days, P=0.065, versus nonuremics) and PTA (exocrine 8.5±1.7, P=0.007, and endocrine 12.6±2.5, P=0.026, versus nonuremics) nonimmunosuppressed recipients. The MST of kidney grafts was not significantly longer in uremic (8.9 ± 2.8 days) than in nonuremic (6.7 ± 1.4 days) SPK recipients (P=0.081). A synchronous kidney transplant and uremia independently down-modulate the rejection response to a pancreas graft, and a simultaneous pancreas graft has no detrimental effect on the survival of a kidney graft. Both factors probably contribute to the relatively good results of a combined pancreas/kidney transplant in diabetic patients with end-stage nephropathy. Clinically, the ability to monitor the kidney for early diagnosis and treatment of rejection episodes gives SPK an additional advantage over PTA.
ISSN:0041-1337
出版商:OVID
年代:1992
数据来源: OVID
|
4. |
EVIDENCE THAT 15‐DEOXYSPERGUALIN INHIBITS NATURAL ANTIBODY PRODUCTION BUT FAILS TO PREVENT HYPERACUTE REJECTION IN A DISCORDANT XENOGRAFT MODEL |
|
Transplantation,
Volume 54,
Issue 1,
1992,
Page 26-31
JOSEPH LEVENTHAL,
HENRY FLORES,
SCOTT GRUBER,
JEANETH FIGUEROA,
JEFFREY PLATT,
J. Manivel,
FRITZ BACH,
ARTHUR MATAS,
R. BOLMAN,
Preview
|
PDF (599KB)
|
|
摘要:
Preventing hyperacute rejection (HAR) is a difficult and unsolved problem in xenotransplantation. This may be due, in part, to a lack of therapies that can suppress production of natural antibodies (NA), which are thought to be critical mediators of HAR. This study examined the effect of 15-deoxyspergualin (DSPG) and splenectomy (Spx) on NA production and return of NA after plasma exchange (PE) in a discordant species combination (strain 2 guinea pig to Lewis rat). A dose of 5 mg/kg/day DSPG + Spx significantly reduced Lewis rat anti-guinea pig NA titer after one week of therapy. Antibody titer was not significantly reduced in rats treated with splenectomy alone. PE alone acutely depleted NA titers; however, complete rebound was seen in 48 hr. When PE was performed in rats treated with DSPG + Spx, an additional significant NA reduction occurred; no rebound 24–48 hr after PE was seen. Except for a 20% reduction in body weight, no serious complications occurred in DSPG + Spx recipients. Despite a profound NA titer reduction, treatment with DSPG, Spx, and PE did not prolong guinea pig cardiac xenograft survival in a clinically significant fashion. Immunopathological study of rejected cardiac xenografts revealed no antibody deposition but persistent complement deposition on vascular endothelium. We conclude that DSPG + Spx effectively inhibits synthesis of rat anti-guinea pig NA, that further NA titer reduction can be achieved with the addition of PE, and that DSPG + Spx prevents post-PE antibody rebound. We also conclude that the limited prolongation in cardiac xenograft survival achieved, despite marked suppression of NA, supports a complement-mediated mechanism of HAR in our animal model.
ISSN:0041-1337
出版商:OVID
年代:1992
数据来源: OVID
|
5. |
THE ROLE OF ULTRAVIOLET B‐IRRADIATED LEUKOCYTE TRANSFUSIONS AND CYCLOSPORINE IN INTESTINAL TRANSPLANTATION |
|
Transplantation,
Volume 54,
Issue 1,
1992,
Page 32-37
FEI XIAO,
PRESTON FOSTER,
HOWARD SANKARY,
ALEXANDER TEMPLETON,
KENT KOCISS,
JAMES WILLIAMS,
Preview
|
PDF (637KB)
|
|
摘要:
To explore the efficacy of ultraviolet B-irradiated donor-specific leukocyte transfusions (UV-DSLT) with short-term cyclosporine to control intestinal allograft rejection, 75 adult Lewis (RT11) rats underwent total small-intestinal transplantation from Brown-Norway (RT1n) donors. Recipients were randomly divided into ten treatment and control groups utilizing various combinations of donor-specific and third-party (Wistar-Furth, RT1u) leukocyte transfusions (TPLT), with or without transfusion UVB irradiation, and either alone or in combination with short-term cyclosporine administration (5 mg/kg intramuscularly on days −7, 0, 1, and 2 relative to transplantation). Leukocytes (108cells) separated from a spleen cell suspension were infused on day −7. Certain transfused leukocytes were treated with 12,000 joules/m of UVB irradiation. Groups were monitored for mean survival time (MST) and cause of death.UV-DSLT alone (MST = 19.8±4.6) or in combination with cyclosporine (UV-DSLT+CsA, MST = 53.1±22.5) significantly (P<0.003–0.0002, Mantel-Cox) prolonged recipient survival when compared with appropriate controls (i.e., no treatment, MST = 11.2±3.4; CsA, MST = 17.2±9.0; UV-TPLT, MST = 12.4±4.0; and UV-TPLT+CsA, MST = 25.1±9.7) No significant increase in graft-versus-host disease occurred in any group, with 85% (64/75) of the recipients dying of acute rejection. Conversely, the UV-DSLT+CsA group had a significant increase (9/11; chi-square, P<0.0001) in chronic rejection. Because UV-DSLT+CsA improved survival as compared with third-party controls, a limited donor-specific unresponsiveness may have been induced. Furthermore, this treatment produces a consistent, chronic rejection rodent intestinal allograft model.
ISSN:0041-1337
出版商:OVID
年代:1992
数据来源: OVID
|
6. |
PATTERNS OF CORNEAL GRAFT REJECTION IN THE RABBIT AND REVERSAL OF REJECTION WITH MONOCLONAL ANTIBODIES |
|
Transplantation,
Volume 54,
Issue 1,
1992,
Page 38-43
KERYN WILLIAMS,
SCOTT STANDFIELD,
SARAH WING,
CHRISTOPHER BARRAS,
RICHARD MILLS,
RAFAELLA COMACCHIO,
DOUGLAS COSTER,
Preview
|
PDF (672KB)
|
|
摘要:
The purpose of this study was to determine whether the local administration of monoclonal antibodies could reverse rabbit corneal graft rejection. To provide a rational basis for the choice of monoclonal antibodies as potential immunosuppressive agents, the phenotypes of cells infiltrating rejecting rabbit corneal allografts were examined by immunohistochemistry. About half the leukocytes accumulating in these grafts bore an immunodominant T cell marker, over two-thirds carried MHC class II antigens, and about one-fifth carried myeloid cell markers. A kinetic study of the cell population appearing in rabbit aqueous during corneal graft rejection was performed by examination of repetitive anterior chamber taps taken over a ten-day period; again, the major components were T cells, MHC class II antigen-positive cells and myeloid cells. Monoclonal antibodies L11/135 (directed against a peripheral T cell determinant), 2C4 (directed against a monomorphic MHC class II antigen), and LION 2 (directed against a myeloid antigen) were chosen for intracameral injection into rabbits with rejecting corneal grafts. Each animal received a total of 50–100 μg of antibody in two injections at 3–4-day intervals. L11/135 and LION 2 reversed rejection in 5/9 and 8/12 animals, respectively, in the absence of any other immunosuppression; 2C4 was without effect. We suggest that monoclonal antibody therapy in corneal transplantation deserves further attention.
ISSN:0041-1337
出版商:OVID
年代:1992
数据来源: OVID
|
7. |
BENEFICIAL EFFECT OF COMBINED 3,5,3′‐TRIIODOTHYRONINE AND VASOPRESSIN ADMINISTRATION ON HEPATIC ENERGY STATUS AND SYSTEMIC HEMODYNAMICS AFTER BRAIN DEATH |
|
Transplantation,
Volume 54,
Issue 1,
1992,
Page 44-49
MASANOBU WASHIDA,
RYOJI OKAMOTO,
DAI MANAKA,
TADASHI YOKOYAMA,
YUZO YAMAMOTO,
KEIICHI INO,
NARITAKA YAMAMOTO,
NOBUHIRO OSAKI,
YASUYUKI SHIMAHARA,
YOSHIO YAMAOKA,
KAORU KUMADA,
KAZUE OZAWA,
Preview
|
PDF (510KB)
|
|
摘要:
The influence of combined replenishment of L-3,5,3′-triiodothyronine (T3) and vasopressin (antidiuretic hormone [ADH]) on both hepatic metabolism and systemic hemodynamics was assessed in brain-dead dogs. Arterial ketone body ratio (AKBR) was measured as a parameter of hepatic metabolism, which reflects the redox state (free nicotinamide adenine dinucleotide/reduced nicotinamide adenine dinucleotide) of liver mitochondria. Mean arterial blood pressure (MAP) was significantly decreased from 110.4±3.8 to 44.4±1.7 mmHg, at 1 hr after completion of brain death (P<0.01). In the control group AKBR was maintained thereafter at near control value of 1.0 with a significant decrease in serum lactate concentration in spite of marked hypotension. T3 infusion at a rate of 1 μg/kg/hr elevated the AKBR but did not elevate MAP. Vasopressin infusion at a rate of 0.1 U/kg/hr sustained AKBR and elevated MAP significantly at 1 hr after administration but tended to decrease thereafter. Combined administration of T3 and ADH elevated the AKBR to about 2.0, and MAP was restored to near-normal level. Other parameters such as glutamic oxaloacetic transaminase, glutamic pyruvic transaminase, and lactic dehydrogenase, reflecting liver cell injury and serum creatinine, and blood urea nitrogen as renal function, were maintained within normal range. These results indicate that combined T3 and vasopressin administration has a beneficial synergistic effect on both hepatic energy metabolism and systemic hemodynamics without any detrimental influence to other conventional parameters. Therefore, it is suggested that this combined administration may contribute to the management of potential multiorgan donors.
ISSN:0041-1337
出版商:OVID
年代:1992
数据来源: OVID
|
8. |
SEQUENTIAL THERAPY—A PROSPECTIVE RANDOMIZED TRIAL OF MALG VERSUS OKT3 FOR PROPHYLACTIC IMMUNOSUPPRESSION IN CADAVER RENAL ALLOGRAFT RECIPIENTS |
|
Transplantation,
Volume 54,
Issue 1,
1992,
Page 50-55
D. FREY,
A. MATAS,
K. GILLINGHAM,
D. CANAFAX,
W. PAYNE,
D. DUNN,
D. SUTHERLAND,
J. NAJARIAN,
Preview
|
PDF (701KB)
|
|
摘要:
We prospectively studied the use of prophylactic Minnesota antilymphocyte globulin vs. OKT3 in kidney transplant recipients. Between 7/1/87 and 9/1/90, 138 adult kidney and 35 kidney-pancreas recipients were randomized after stratification for age (18–49 vs. ≥50), diabetes (diabetic vs. nondiabetic), transplant number (1 vs. >1) and, for retransplants, the length of survival of the first graft (<1 year vs. ≥1 year), and then randomized to receive 7 days of either MALG (20 mg/kg/day) or OKT3 (5 mg/day). Immunosuppression was otherwise identical in both groups; prednisone and azathioprine started on the day of surgery, and cyclosporine started on postoperative day 6. Minimum follow-up was 9 months. There was no difference in one- and two-year actuarial patient or graft survival rates, incidence of rejection, or serum creatinine level. MALG was associated with a higher incidence of cytomegalovirus; it was statistically significant in the subgroup of CMV seronegative recipients of kidneys from seropositive donors (P<.05). OKT3 was more expensive and was associated with significantly more side effects: fever (P<.0001), dyspnea (P=.04), and acute respiratory distress syndrome (ARDS) (P=.02).
ISSN:0041-1337
出版商:OVID
年代:1992
数据来源: OVID
|
9. |
DAILY RENAL HYPOPERFUSION INDUCED BY CYCLOSPORINE IN PATIENTS WITH RENAL TRANSPLANTATION |
|
Transplantation,
Volume 54,
Issue 1,
1992,
Page 56-60
NORBERTO PERICO,
PIERO RUGGENENTI,
FLAVIO GASPARI,
LIDIA MOSCONI,
ARIELA BENIGNI,
CARMEN AMUCHASTEGUI,
FABIO GASPARINI,
GIUSEPPE REMUZZI,
Preview
|
PDF (520KB)
|
|
摘要:
A variety of side effects are associated with the use of cyclosporine, the most relevant of which remains the renal toxicity. We did parallel studies on cyclosporine pharmacokinetics and renal function in patients who had a recent kidney transplant and were given cyclosporine as a part of their immunosuppressive therapy. Seven consecutive renal transplant patients were studied at the end of a month of treatment while on different oral cyclosporine doses (5, 3.5, 2.5, or 1.5 mg/kg, twice a day, respectively). Cyclosporine pharmacokinetics profiles and renal function parameters (GFR and renal plasma flow [RPF], as inulin and p-amino hippurate clearances, respectively) were determined before and over a 12-hr period after each single dose of cyclosporine. Plasma levels and urinary excretion rate of endothelin were also studied before and after the highest cyclosporine dose (5 mg/kg). Mean trough levels, area under the curve values, and maximum concentration of blood cyclosporine were comparable after 5 and 3.5 mg/kg cyclosporine and decreased in a dose-dependent manner after the lower doses (2.5 and 1.5 mg/kg). In the same patients GFR declined on average 63%, 53%, 35%, and 18%, 2–4 hr after maximum cyclosporine concentration was reached. As blood levels of cyclosporine returned to trough, GFR progressively increased to baseline. Similar results were found for RPF; 5 mg/kg cyclosporine did not modify endothelin plasma levels. By contrast, urinary excretion of the peptide increased significantly (P<0.01) in the 6 hr that followed cyclosporine administration and returned within the normal range in the subsequent 6 hr. Following each oral administration of cyclosporine, 2–4 hr after peak blood concentration was reached, patients showed renal hy-poperfusion, transient and rapidly reversible. This was associated with an increased urinary endothelin excretion rate that was also transient.It is speculated that an excessive renal synthesis of endothelin is the cause of the daily renal hypoperfusion observed in patients with renal transplants given cyclosporine.
ISSN:0041-1337
出版商:OVID
年代:1992
数据来源: OVID
|
10. |
HYPERACUTE AND ACUTE KIDNEY GRAFT REJECTION DUE TO ANTIBODIES AGAINST B CELLS |
|
Transplantation,
Volume 54,
Issue 1,
1992,
Page 61-64
JUAN SCORNIK,
WILLIAM LEFOR,
JAMES CICCIARELLI,
MATTHEW BRUNSON,
THOMAS BOGAARD,
RICHARD HOWARD,
JOHN ACKERMANN,
ROBERT MENDEZ,
DANA SHIRES,
WILLIAM PFAFF,
Preview
|
PDF (448KB)
|
|
摘要:
Because of the perception of its uncertain clinical significance, the B cell crossmatch is not universally performed before renal transplantation. Even though sporadic cases of hyperacute rejection associated with B cell antibodies have been reported, doubts remain in light of other studies suggesting no effect on graft survival. This report describes 4 cases of graft rejection (3 hyperacute and 1 acute) that occurred in patients with anti-B-cell antibodies specific against donor HLA-DR or DQ antigens. Absence of anti-donor class I antibodies was confirmed in all cases by 2-color flow cytometry. Strong evidence for an antibody-mediated mechanism was found in one patient with anti-class I and anti-class II antibodies in serum transplanted with a class II mismatched kidney. In this case, only anti-class II antibodies were recovered in the eluate of the nephrectomy specimen. These four cases were compiled from three different institutions over a four-year period, which confirms the infrequent occurrence of these events. While anti-class II antibodies may not always be detrimental for graft survival, these results also confirm that they have the potential to cause hyperacute or acute graft loss. We conclude that the information provided by the B cell crossmatch should be available at the time that a decision to proceed with a renal transplant is made.
ISSN:0041-1337
出版商:OVID
年代:1992
数据来源: OVID
|
|